Terms: = Lymphoma AND VHL, HRCA1, P40337, 7428, ENSG00000134086, RCA1, VHL1 AND Treatment
10 results:
1. The PROTAC selectively degrading Bcl-x
Zhang S; Chen Y; Xu Z; Yang J; Sun R; Wang J; Sun Y; Jiang B; Yang X; Tan W
Theranostics; 2022; 12(17):7476-7490. PubMed ID: 36438482
[No Abstract] [Full Text] [Related]
2. Clear Cell Renal Carcinoma: MicroRNAs With Efficacy in Preclinical
Weidle UH; Nopora A
Cancer Genomics Proteomics; 2021; 18(3 Suppl):349-368. PubMed ID: 33994361
[TBL] [Abstract] [Full Text] [Related]
3. Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance.
Sun N; Ren C; Kong Y; Zhong H; Chen J; Li Y; Zhang J; Zhou Y; Qiu X; Lin H; Song X; Yang X; Jiang B
Eur J Med Chem; 2020 May; 193():112190. PubMed ID: 32179332
[TBL] [Abstract] [Full Text] [Related]
4. ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review.
Bodokh Y; Ambrosetti D; Kubiniek V; Tibi B; Durand M; Amiel J; Pertuit M; Barlier A; Pedeutour F
Cancer Genet; 2018 Feb; 221():31-37. PubMed ID: 29405994
[TBL] [Abstract] [Full Text] [Related]
5. Dual and Specific Inhibition of NAMPT and PAK4 By KPT-9274 Decreases Kidney Cancer Growth.
Abu Aboud O; Chen CH; Senapedis W; Baloglu E; Argueta C; Weiss RH
Mol Cancer Ther; 2016 Sep; 15(9):2119-29. PubMed ID: 27390344
[TBL] [Abstract] [Full Text] [Related]
6. The genetic basis of intradural spinal tumors and its impact on clinical treatment.
Karsy M; Guan J; Sivakumar W; Neil JA; Schmidt MH; Mahan MA
Neurosurg Focus; 2015 Aug; 39(2):E3. PubMed ID: 26235020
[TBL] [Abstract] [Full Text] [Related]
7. HDAC inhibitors and decitabine are highly synergistic and associated with unique gene-expression and epigenetic profiles in models of DLBCL.
Kalac M; Scotto L; Marchi E; Amengual J; Seshan VE; Bhagat G; Ulahannan N; Leshchenko VV; Temkin AM; Parekh S; Tycko B; O'Connor OA
Blood; 2011 Nov; 118(20):5506-16. PubMed ID: 21772049
[TBL] [Abstract] [Full Text] [Related]
8. Prognostic significance of aberrant promoter hypermethylation of CpG islands in patients with diffuse large B-cell lymphomas.
Amara K; Trimeche M; Ziadi S; Laatiri A; Hachana M; Korbi S
Ann Oncol; 2008 Oct; 19(10):1774-86. PubMed ID: 18539616
[TBL] [Abstract] [Full Text] [Related]
9. Microsatellite instability assessment in prediction of drug resistance in childhood Burkitt's and large cell diffuse malignant non-Hodgkin lymphoma (MNHL).
Yhap M; Pyesmany AF; Ball LM; Riddle DC; Mu J; van Velzen D
Adv Exp Med Biol; 1999; 457():517-25. PubMed ID: 10500829
[TBL] [Abstract] [Full Text] [Related]
10. Shedding of CD9 antigen into cerebrospinal fluid by acute lymphoblastic leukemia cells.
Komada Y; Ochiai H; Shimizu K; Azuma E; Kamiya H; Sakurai M
Blood; 1990 Jul; 76(1):112-6. PubMed ID: 2364164
[TBL] [Abstract] [Full Text] [Related]